A detailed history of Ellis Investment Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 19,455 shares of INCY stock, worth $1.44 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
19,455
Previous 19,756 1.52%
Holding current value
$1.44 Million
Previous $1.31 Million 2.91%
% of portfolio
0.27%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$65.08 - $83.38 $19,589 - $25,097
-301 Reduced 1.52%
19,455 $1.34 Million
Q3 2024

Oct 24, 2024

BUY
$57.33 - $68.61 $54,463 - $65,179
950 Added 5.05%
19,756 $1.31 Million
Q2 2024

Aug 06, 2024

BUY
$51.18 - $63.75 $962,491 - $1.2 Million
18,806 New
18,806 $1.14 Million
Q2 2019

Jul 24, 2019

BUY
$73.52 - $88.7 $2,132 - $2,572
29 New
29 $2,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ellis Investment Partners, LLC Portfolio

Follow Ellis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.